Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV

Kristin L. DeBord, Deborah M. Anderson, Melanie M. Marketon, Katie A. Overheim, R. William DePaolo, Nancy A. Ciletti, Bana Jabri, Olaf Schneewind

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

In contrast to Yersinia pestis LcrV, the recombinant V10 (rV10) variant (lacking residues 271 to 300) does not suppress the release of proinflammatory cytokines by immune cells. Immunization with rV10 generates robust antibody responses that protect mice against bubonic plague and pneumonic plague, suggesting that rV10 may serve as an improved plague vaccine.

Original languageEnglish
Pages (from-to)4910-4914
Number of pages5
JournalInfection and Immunity
Volume74
Issue number8
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV'. Together they form a unique fingerprint.

Cite this